Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (21 ops.)
Latest filing published 13 Jul 2026 for Arcus Biosciences, Inc., €1.3M. Read the official filing
Filing timeline
BuySaleJuan C. Jaen
Insider track record
Disclosed buys
0
Disclosed sells
21
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Juan C. Jaen: trading record in brief
Juan C. Jaen (chief executive) discloses dealings in Arcus Biosciences, Inc. to SEC (Form 4). In total, 31 filings cover trades dated from 16 June 2021 to 10 July 2026.
No open-market purchase appears, only 21 sales worth €5.8M. The totals do not cover 4 filings with an undisclosed amount. The rest of the record consists of 7 share grants. 2026 to date brings no purchases and 8 sales.
Most recently, on 13 July 2026, the filings show an open-market sale worth €1.3M in Arcus Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Juan C. Jaen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
48,502 shares@ US$30.0530.041% mcap20.3% of flowCommon StockSEC:0001422996-26-000006:0
19,799 shares@ US$28.6080.016% mcap7.9% of flowCommon StockSEC:0001422996-26-000006:1
268 shares@ US$29.3970.0002% mcap0.1% of flowCommon StockSEC:0001422996-26-000006:2
9,236 sharesCommon StockSEC:0001610717-26-000294:0
14,067 sharesCommon StockSEC:0001610717-26-000294:1
1,697 sharesCommon StockSEC:0001610717-26-000294:2
6,431 sharesCommon StockSEC:0001610717-26-000294:3
31,000 shares0Common StockSEC:0001422996-26-000004:0
29,670 shares@ US$21.340.018% mcap10.0% of flowCommon StockSEC:0001422996-26-000002:0
11,225 shares@ US$21.88434.6% of flowCommon StockSEC:0001422996-25-000015:0
82,997 shares@ US$24.70690.059% mcap32.4% of flowCommon StockSEC:0001422996-25-000011:0
37,114 shares@ US$20.227415.0% of flowCommon StockSEC:0001422996-25-000009:0
4,314 shares@ US$20.31752.1% of flowCommon StockSEC:0001422996-25-000007:0
19,019 shares@ US$20.18740.011% mcap6.1% of flowCommon StockSEC:0001422996-25-000005:0
50,000 shares0Common StockSEC:0001724521-25-000014:0
17,286 shares@ US$16.084.2% of flowCommon StockSEC:0001724521-24-000178:0
6,969 shares@ US$16.971.8% of flowCommon StockSEC:0001724521-24-000128:0
3,900 shares@ US$20.061.2% of flowCommon StockSEC:0001724521-24-000062:0
40,000 shares0Common StockSEC:0001724521-24-000029:0
6,975 shares@ US$20.092.0% of flowCommon StockSEC:0001724521-24-000008:0
6,128 shares@ US$17.741.6% of flowCommon StockSEC:0001724521-23-000065:0
6,000 shares0Common StockSEC:0001209191-23-038154:0
45,800 shares0Common StockSEC:0001209191-23-004872:0
3,735 shares@ US$30.661.7% of flowCommon StockSEC:0001209191-22-061759:0
748 shares@ US$21.710.2% of flowCommon StockSEC:0001209191-22-038386:1
25 of 31 declarations
